Instil Bio

Instil Bio

Biotechnology, 3963 Maple Ave, Dallas, Texas, 75219, United States, 51-200 Employees

instilbio.com

  • twitter
  • LinkedIn

phone no Phone Number: 24********

Who is INSTIL BIO

Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patients own T cells harvested from the patients t...

Read More

map
  • 3963 Maple Ave, Dallas, Texas, 75219, United States Headquarters: 3963 Maple Ave, Dallas, Texas, 75219, United States
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $100 Million to $250 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from INSTIL BIO

Instil Bio Org Chart and Mapping

VP-Level

James Stutz

VP of Business Development

Employees

MSC Rohit Gehani

Associate Director, Qc Analytical and Raw Materials Testing

Igor Segal

Chief Executive Officer

Natasha Bat

Senior Accounts Payable

Paul Robbins

Vice President, Head of Translational Medicine

Jeff McLeroy

Senior Director, Clinical Development

Poornesh Ponnekanti

Senior Validation Project Engineer

Maize Wang

Senior Process Engineer

Javier Garcia

Environment, Health and Safety Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Instil Bio

Answer: Instil Bio's headquarters are located at 3963 Maple Ave, Dallas, Texas, 75219, United States

Answer: Instil Bio's phone number is 24********

Answer: Instil Bio's official website is https://instilbio.com

Answer: Instil Bio's revenue is $100 Million to $250 Million

Answer: Instil Bio's SIC: 2836

Answer: Instil Bio's NAICS: 561110

Answer: Instil Bio has 51-200 employees

Answer: Instil Bio is in Biotechnology

Answer: Instil Bio contact info: Phone number: 24******** Website: https://instilbio.com

Answer: Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patients own T cells harvested from the patients tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access